Peptide aptamer based on natural protein ligand for C reactive protein detection

Author:

Chen Xi1,Cui Lili2,Liu Tonggong3,Zhang Ran2,Chen Hongfang4,Zhao Xiaona3,Peng Qiang1,Li Huawen4,Gu Dayong3

Affiliation:

1. Shenzhen Luohu People's Hospital

2. Shenzhen International Travel Health Care Center

3. Shenzhen Second People's Hospital

4. Guangdong Medical University

Abstract

Abstract As a substitute for traditional antibodies, peptide aptamers have received extensive attention in recent years. However, the current research can only screen peptide aptamers from antibody sequence structures. This study changed the inherent idea that peptide aptamers were derived from antibodies in the past. Screening of peptide aptamers derived from natural protein ligands ( complement C1q ) of C-reactive proteinby bioinformatics technology to achieve specific detection of CRP, and establishing a CRP detection method in which peptide aptamers replace traditional antibodies to play a capture role. It is proved that peptide aptamers derived from natural protein ligands are feasible for detecting antigens. The results showed that the peptide aptamer C199 − 207m screened by bioinformatics could specifically bind to CRP, and the established sandwich ELISA technology with capture function of peptide aptamer C199 − 207m could be used to detect CRP with good accuracy, specificity, repeatability, sensitivity and ideal detection range. Peptide aptamers based on natural protein ligands replace traditional antibodies to capture antigens, which is a new attempt that can be applied to the immunoassay of CRP or related proteins.

Publisher

Research Square Platform LLC

Reference37 articles.

1. C-reactive Protein;Black S;J Biol Chem,2004

2. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus;Enocsson H;J Clin Med,2021

3. C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period;Świątkiewicz I;Int J Mol Sci,2021

4. C-Reactive Protein Velocity (CRPv) as a New Biomarker for the Early Detection of Acute Infection/Inflammation;Levinson T;Int J Mol Sci,2022

5. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights;Hart PC;Front Immunol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3